Dingli Liu
Guangzhou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Immune Checkpoint Inhibitor-Induced Rapid Decline in Hepatitis B Virus Markers Improves the Prognosis of Hepatitis B Virus-Related Hepatocellular Carcinoma Patients.
Journal: The Journal of infectious diseases
Published: October 16, 2025
Clinical efficacy and safety of icaritin in patients with hepatocellular carcinoma: a real-world study.
Journal: Frontiers in pharmacology
Published: August 01, 2025
Identification of candidate diagnostic and prognostic biomarkers for pancreatic carcinoma.
Journal: EBioMedicine
Published: August 08, 2018
Knockdown of long non-coding RNA MALAT1 inhibits growth and motility of human hepatoma cells via modulation of miR-195.
Journal: Journal of cellular biochemistry
Published: April 01, 2017
microRNA-489 Plays an Anti-Metastatic Role in Human Hepatocellular Carcinoma by Targeting Matrix Metalloproteinase-7.
Journal: Translational oncology
Published: December 12, 2016
Synergistic anti-tumor efficacy of sorafenib and fluvastatin in hepatocellular carcinoma.
Journal: Oncotarget
Published: November 09, 2016
Zinc finger protein ZBTB20 is an independent prognostic marker and promotes tumor growth of human hepatocellular carcinoma by repressing FoxO1.
Journal: Oncotarget
Published: September 27, 2015
MicroRNA-520g induces epithelial-mesenchymal transition and promotes metastasis of hepatocellular carcinoma by targeting SMAD7.
Journal: FEBS letters
Published: October 19, 2014
Showing 1-8 of 8
Last Updated: 09/26/2026